Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a Peroxisome Biogenesis Disorder (PBD), which is a rare inherited condition affecting how cells process certain fats and substances
- People who have a defect in a single peroxisome enzyme or protein, where the symptoms and presentation are similar to a Peroxisome Biogenesis Disorder (confirm with trial site)
Who may not be able to join:
- People whose condition is not a Peroxisome Biogenesis Disorder
- People whose condition is not a single peroxisome enzyme or protein defect with a presentation similar to a Peroxisome Biogenesis Disorder
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nancy E Braverman, MD, MS, McGill University Health Center, Montreal Childrens Hopital
Phone: (1) 514-934-1934
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Documentation of the clinical findings
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.